These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9009582)

  • 41. The role of chemotherapy for skull base carcinomas and sarcomas.
    Adelstein DJ
    Neurosurg Clin N Am; 2000 Oct; 11(4):681-91. PubMed ID: 11082178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Adjuvant chemotherapy in early soft tissue sarcoma and palliative chemotherapy in advanced soft tissue sarcoma in adults].
    Sauer H
    Praxis (Bern 1994); 1998 Aug; 87(34):1066-71. PubMed ID: 9757790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current trials and new aspects in soft tissue sarcoma of adults.
    Issels RD; Schlemmer M
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug repositioning in sarcomas and other rare tumors.
    Lee ATJ; Huang PH; Pollack SM; Jones RL
    EBioMedicine; 2016 Apr; 6():4-5. PubMed ID: 27211532
    [No Abstract]   [Full Text] [Related]  

  • 45. [Cancer chemotherapeutic agents].
    Sato Y; Morita M; Watanabe T
    Jibiinkoka; 1969 Oct; 40(10):817-25. PubMed ID: 5812653
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of sarcomas: thinking out-of-the-box.
    Muggia FM; Pavlick A
    Cancer Invest; 2003 Apr; 21(2):321-2. PubMed ID: 12743996
    [No Abstract]   [Full Text] [Related]  

  • 47. Cut to the chase: on the need for genotype-specific soft tissue sarcoma trials.
    Gupta A; Church D; Barnes D; Hassan AB
    Ann Oncol; 2009 Mar; 20(3):399-400. PubMed ID: 19246418
    [No Abstract]   [Full Text] [Related]  

  • 48. Chemotherapy of sarcoma.
    Wiltshaw E; McKinna JA; Harmer CL; Gowing N
    J R Soc Med; 1982 Jun; 75(6):385-7. PubMed ID: 7086785
    [No Abstract]   [Full Text] [Related]  

  • 49. [Musculoskeletal Tumor].
    Chuman H
    Gan To Kagaku Ryoho; 2017 Mar; 44(3):211. PubMed ID: 28400542
    [No Abstract]   [Full Text] [Related]  

  • 50. Effectiveness of chemotherapy in non-rhabdomyosarcoma soft tissue sarcomas.
    Ferrari A; Collini P
    Pediatr Blood Cancer; 2005 Aug; 45(2):226-7; author reply 228. PubMed ID: 15782404
    [No Abstract]   [Full Text] [Related]  

  • 51. Controversies in surgical oncology: routine anthracycline-based adjuvant chemotherapy for stage III extremity soft tissue sarcoma.
    Bramwell VH
    Ann Surg Oncol; 2007 Apr; 14(4):1254-6. PubMed ID: 17103260
    [No Abstract]   [Full Text] [Related]  

  • 52. Adjuvant therapy for soft tissue sarcomas.
    Lewis JJ; Benedetti F
    Surg Oncol Clin N Am; 1997 Oct; 6(4):847-62. PubMed ID: 9309097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Indication of chemotherapy according to histological type of musculoskeletal sarcomas].
    Goto T; Okuma T; Ogura K; Imanishi J; Hozumi T; Kondo T
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):199-203. PubMed ID: 19223736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy for soft tissue sarcomas.
    Clark JW
    Med Health R I; 1997 Jan; 80(1):37-8. PubMed ID: 9009582
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.